123 related articles for article (PubMed ID: 11280503)
1. Effects of intraperitoneal cefazolin on mesothelial cells in noninfected CAPD patients.
Manley HJ; Bailie GR
Perit Dial Int; 2001; 21(1):83-5. PubMed ID: 11280503
[No Abstract] [Full Text] [Related]
2. Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics.
Diaz-Buxo JA; Crawford TL; Bailie GR
Perit Dial Int; 2001; 21 Suppl 3():S197-201. PubMed ID: 11887820
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
Manley HJ; Bailie GR; Asher RD; Eisele G; Frye RF
Perit Dial Int; 1999; 19(1):65-70. PubMed ID: 10201343
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
Low CL; Gopalakrishna K; Lye WC
J Am Soc Nephrol; 2000 Jun; 11(6):1117-1121. PubMed ID: 10820176
[TBL] [Abstract][Full Text] [Related]
5. Effects of intraperitoneal antibiotics on human peritoneal mesothelial cell growth.
Yen CJ; Tsai TJ; Chen HS; Fang CC; Yang CC; Lee PH; Lin RH; Tsai KS; Hung KY; Yen TS
Nephron; 1996; 74(4):694-700. PubMed ID: 8956303
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal cefazolin and ceftazidime effects on human peritoneal mesothelial cell release of cancer antigen-125.
Manley HJ; Elwell RJ; Bailie GR; Welch CL
Ann Pharmacother; 2004 Dec; 38(12):2035-40. PubMed ID: 15536141
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal cefazolin and gentamicin in the management of CAPD-related peritonitis.
Weber J; Kuhlmann U
Contrib Nephrol; 1991; 89():108-18. PubMed ID: 1893715
[No Abstract] [Full Text] [Related]
9. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters.
Lai KN; Lai KB; Szeto CC; Ho KK; Poon P; Lam CW; Leung JC
Am J Kidney Dis; 1997 May; 29(5):699-705. PubMed ID: 9159303
[TBL] [Abstract][Full Text] [Related]
10. Correlation of intraperitoneal antibiotic pharmacokinetics and peritoneal membrane transport characteristics.
Elwell RJ; Bailie GR; Manley HJ
Perit Dial Int; 2000; 20(6):694-8. PubMed ID: 11216561
[TBL] [Abstract][Full Text] [Related]
11. Initial treatment of CAPD peritonitis: poor response with association of cefazolin and amikacin.
Onozato ML; Caramori JC; Barretti P
Perit Dial Int; 1999; 19(1):88-9. PubMed ID: 10201353
[No Abstract] [Full Text] [Related]
12. Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.
Lui SL; Cheng SW; Ng F; Ng SY; Wan KM; Yip T; Tse KC; Lam MF; Lai KN; Lo WK
Kidney Int; 2005 Nov; 68(5):2375-80. PubMed ID: 16221243
[TBL] [Abstract][Full Text] [Related]
13. Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.
Peerapornratana S; Chariyavilaskul P; Kanjanabuch T; Praditpornsilpa K; Eiam-Ong S; Katavetin P
Perit Dial Int; 2017; 37(2):218-224. PubMed ID: 27738089
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin].
König U; Müller U; Binswanger U
Klin Wochenschr; 1987 Jul; 65(12):562-70. PubMed ID: 3498086
[TBL] [Abstract][Full Text] [Related]
15. Acute bacterial peritonitis: permeability of cephalosporins in the peritoneal cavity.
Eyal A; Greif F; Shalit I; Lelcuk S
Isr J Med Sci; 1996 Dec; 32(12):1317-9. PubMed ID: 9007180
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis.
Lai MN; Kao MT; Chen CC; Cheung SY; Chung WK
Perit Dial Int; 1997; 17(1):87-9. PubMed ID: 9068030
[No Abstract] [Full Text] [Related]
17. Neutrophil gelatinase-associated lipocalin in peritoneal dialysis reflects status of peritoneum.
Lacquaniti A; Chirico V; Mondello S; Buemi A; Lupica R; Fazio MR; Buemi M; Aloisi C
J Nephrol; 2013; 26(6):1151-9. PubMed ID: 23807648
[TBL] [Abstract][Full Text] [Related]
18. Is monotherapy with cefazolin or ofloxacin an adequate treatment for peritonitis in CAPD patients?
Gucek A; Bren AF; Lindic J; Hergouth V; Mlinsek D
Adv Perit Dial; 1994; 10():144-6. PubMed ID: 7999813
[TBL] [Abstract][Full Text] [Related]
19. Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis.
Bunke CM; Aronoff GR; Brier ME; Sloan RS; Luft FC
Clin Pharmacol Ther; 1983 Jan; 33(1):66-72. PubMed ID: 6848301
[TBL] [Abstract][Full Text] [Related]
20. Oral treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
Searle M; Raman GV
Clin Nephrol; 1985 May; 23(5):241-4. PubMed ID: 4006333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
